Effects of oral morphine on experimentally evoked itch and pain: a randomized, double-blind, placebo-controlled trial

被引:1
作者
Okutani, Hiroai [1 ,3 ]
Lo Vecchio, Silvia [1 ,2 ]
Ammitzboll, Nadia [4 ]
Drewes, Asbjorn Mohr [4 ]
Arendt-Nielsen, Lars [1 ,4 ,5 ]
机构
[1] Aalborg Univ, Ctr Neuroplast & Pain, Sch Med, Dept Hlth Sci & Technol, Aalborg, Denmark
[2] Selma Lagerlofs Vej 249, DK-9260 Gistrup, Denmark
[3] Hyogo Med Univ, Dept Anaesthesiol & Pain Med, Nishinomiya, Hyogo, Japan
[4] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Mech Sense, Aalborg, Denmark
[5] Aalborg Univ Hosp, Clin Inst, Steno Diabet Ctr North Denmark, Aalborg, Denmark
关键词
pain; analgesia; opioid-induced itch; experimentally evoked itch; histamine; cowhage; MU-OPIOID RECEPTORS; INDUCED PRURITUS; MODELS; RESPONSES; MECHANISMS; MANAGEMENT; ANALGESIA; OPIATE;
D O I
10.1515/sjpain-2023-0034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Pain and itch share similar neuronal networks; hence, it is difficult to explain why opioids can relieve pain but provoke itching. The present human volunteer study aimed to investigate the similarities and differences in responses to experimentally provoked pain and itching to explore the underlying fundamental mechanisms.Methods: Twenty-four healthy volunteers were enrolled in this single-center, randomized, double-blind, placebo-controlled, parallel-group trial. Three volar forearms and two mandibular areas were marked, and participants randomly received morphine (20 mg) or identical placebo tablets. Heat, cold, and pressure pain thresholds, and vasomotor responses were assessed at baseline and after oral morphine administration. Itch provocations were induced by intradermal application of 1 % histamine or a topical cowhage (non-histaminergic itch) to a marked area of the skin. The participants were subsequently asked to rate their itching and pain intensities. The assessments were repeated for all marked areas.Results: Morphine caused analgesia, as assessed by the significant modulation of cold and pressure pain thresholds (p<0.05). There were no significant differences in histaminergic or non-histaminergic itch or pain intensity between the morphine and placebo groups. Superficial blood perfusion (vasomotor response) following histamine provocation was significantly increased by morphine (p<0.05) in both areas. No correlation was found between the provoked itch intensity and analgesic efficacy in any area or group.Conclusions: Oral administration of morphine caused analgesia without modulating itch intensities but increased neurogenic inflammation in response to histamine, suggesting that different opioid mechanisms in histaminergic and non-histaminergic neurons evoke neurogenic inflammation.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 44 条
[1]  
Andersen HH, 2017, ITCH, V2, P2
[2]   A Test-Retest Reliability Study of Human Experimental Models of Histaminergic and Non-histaminergic Itch [J].
Andersen, Hjalte H. ;
Sorensen, Anne-Kathrine R. ;
Nielsen, Gebbie A. R. ;
Molgaard, Marianne S. ;
Stilling, Pernille ;
Boudreau, Shellie A. ;
Elberling, Jesper ;
Arendt-Nielsen, Lars .
ACTA DERMATO-VENEREOLOGICA, 2017, 97 (02) :198-207
[3]   Human Surrogate Models of Histaminergic and Non-histaminergic Itch [J].
Andersen, Hjalte H. ;
Elberling, Jesper ;
Arendt-Nielsen, Lars .
ACTA DERMATO-VENEREOLOGICA, 2015, 95 (07) :771-777
[4]   Opioid-induced mast cell activation and vascular responses is not mediated by μ-opioid receptors:: An in vivo microdialysis study in human skin [J].
Blunk, JA ;
Schmelz, M ;
Zeck, S ;
Skov, P ;
Likar, R ;
Koppert, W .
ANESTHESIA AND ANALGESIA, 2004, 98 (02) :364-370
[5]   In silico (computed) modelling of doses and dosing regimens associated with morphine levels above international legal driving limits [J].
Boland, Jason W. ;
Johnson, Miriam ;
Ferreira, Diana ;
Berry, David J. .
PALLIATIVE MEDICINE, 2018, 32 (07) :1222-1232
[6]   Many parallels between itch and pain research [J].
Carstens, E. .
EUROPEAN JOURNAL OF PAIN, 2016, 20 (01) :5-7
[7]   INDUCTION OF HUMAN CUTANEOUS MAST-CELL DE-GRANULATION BY OPIATES AND ENDOGENOUS OPIOID-PEPTIDES - EVIDENCE FOR OPIATE AND NONOPIATE RECEPTOR PARTICIPATION [J].
CASALE, TB ;
BOWMAN, S ;
KALINER, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (06) :775-781
[8]   Strategies to manage the adverse effects of oral morphine: An evidence-based report [J].
Cherny, N ;
Ripamonti, C ;
Pereira, J ;
Davis, C ;
Fallon, M ;
McQuay, H ;
Mercadante, S ;
Pasternak, G ;
Ventafridda, V .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) :2542-2554
[9]  
COUSINS MJ, 1984, ANESTHESIOLOGY, V61, P276
[10]   Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines [J].
Dunteman, E ;
Karanikolas, M ;
Filos, KS .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1996, 12 (04) :255-260